Chris O'Brien Lifehouse

Chris O'Brien Lifehouse Chris Oโ€™Brien Lifehouse is a not-for-profit, comprehensive cancer hospital based in Sydney, Australia When it comes to cancer care, choose hope

๐’๐ฎ๐ซ๐…๐ž๐›๐ซ๐ฎ๐š๐ซ๐ฒ ๐ฌ๐ญ๐š๐ซ๐ญ๐ฌ ๐ญ๐ก๐ข๐ฌ ๐ฐ๐ž๐ž๐ค๐ž๐ง๐! From Sunday, take on the daily challenge to catch a wave a day in February to raise fun...
30/01/2026

๐’๐ฎ๐ซ๐…๐ž๐›๐ซ๐ฎ๐š๐ซ๐ฒ ๐ฌ๐ญ๐š๐ซ๐ญ๐ฌ ๐ญ๐ก๐ข๐ฌ ๐ฐ๐ž๐ž๐ค๐ž๐ง๐!

From Sunday, take on the daily challenge to catch a wave a day in February to raise funds for cancer research.

Surf, swim or splash; every dip helps support vital cancer research at Chris Oโ€™Brien Lifehouse. Your support enables innovative projects through the SurFebruary Cancer Research Seed Fund, making a difference for those living with cancer, now and into the future.

There is still time to register! Sign up here -https://www.surfebruary.com/

Be a part of the ripple effect. The more people who jump in, the bigger the swell of impact.

๐‚๐ž๐ซ๐ฏ๐ข๐œ๐š๐ฅ ๐‚๐š๐ง๐œ๐ž๐ซ ๐€๐ฐ๐š๐ซ๐ž๐ง๐ž๐ฌ๐ฌ ๐Œ๐จ๐ง๐ญ๐กCervical Cancer Awareness Month is a reminder that cervical cancer is one of the most pre...
29/01/2026

๐‚๐ž๐ซ๐ฏ๐ข๐œ๐š๐ฅ ๐‚๐š๐ง๐œ๐ž๐ซ ๐€๐ฐ๐š๐ซ๐ž๐ง๐ž๐ฌ๐ฌ ๐Œ๐จ๐ง๐ญ๐ก

Cervical Cancer Awareness Month is a reminder that cervical cancer is one of the most preventable cancers, and Australia is leading the way in making its elimination possible.

The National Strategy for the Elimination of Cervical Cancer aims to eliminate this disease by 2035. Prevention is central to achieving this goal, and the combination of the HPV vaccination and the National Cervical Screening Program is key.

HPV vaccination protects against the virus responsible for most cervical cancers, while cervical screening detects HPV early, before cancer develops. Together, these measures provide the strongest defence. Vaccination does not eliminate the need for regular screening, as early-stage cervical cancer rarely causes symptoms.

Dr Robyn Sayer, COBL Gynaecological Oncologist, notes; โ€œAustralia is leading the way to eliminating cervical cancer in our lifetime! We are all essential in achieving this historic medical victory โ€“ HPV vaccination, cervical screening and advocating to improve access to all Australians.โ€

This month is an opportunity to raise awareness and encourage action. Booking a Cervical Screening Test, talking to a GP about the HPV vaccine, or supporting someone to do the same are small steps that can make a life-saving difference.

With both vaccination and screening, prevention works, early detection saves lives, and together, Australia can achieve the bold target of eliminating cervical cancer by 2035.

๐“๐ซ๐š๐๐ข๐ญ๐ข๐จ๐ง๐š๐ฅ ๐˜๐ข๐๐š๐ค๐ข ๐’๐จ๐ฎ๐ง๐ ๐‡๐ž๐š๐ฅ๐ข๐ง๐ : ๐‘๐ž๐ญ๐ฎ๐ซ๐ง๐ฌ ๐ข๐ง 2026On the last Friday of each month, we invite our community to come toget...
27/01/2026

๐“๐ซ๐š๐๐ข๐ญ๐ข๐จ๐ง๐š๐ฅ ๐˜๐ข๐๐š๐ค๐ข ๐’๐จ๐ฎ๐ง๐ ๐‡๐ž๐š๐ฅ๐ข๐ง๐ : ๐‘๐ž๐ญ๐ฎ๐ซ๐ง๐ฌ ๐ข๐ง 2026

On the last Friday of each month, we invite our community to come together for a Traditional Yidaki Sound Healing.

Patients, families, staff and community members are welcome to take part in a supportive experience that sits alongside clinical care, helping to reduce the emotional and physical impact of cancer.

Grounded in cultural practice and delivered with care and respect, these sessions reflect our commitment to compassionate, integrated support that nurtures wellbeing beyond treatment.

Our first sound healing for the year will be held this Friday in The LivingRoom Atrium from 6:00โ€“7:30pm.

RSVP to secure your place: https://events.humanitix.com/aboriginal-traditional-sound-healing-at-chris-o-brien-lifehouse-2026

๐‚๐š๐ข๐ญ๐ฅ๐ข๐ง ๐ƒ๐ž๐ฅ๐š๐ง๐ž๐ฒ ๐€๐Œ ๐‘๐ž๐œ๐จ๐ ๐ง๐ข๐ฌ๐ž๐ ๐ข๐ง ๐€๐ฎ๐ฌ๐ญ๐ซ๐š๐ฅ๐ข๐š ๐ƒ๐š๐ฒ 2026 ๐‡๐จ๐ง๐จ๐ฎ๐ซ๐ฌ ๐‹๐ข๐ฌ๐ญCongratulations to Caitlin Delaney AM on being recognise...
27/01/2026

๐‚๐š๐ข๐ญ๐ฅ๐ข๐ง ๐ƒ๐ž๐ฅ๐š๐ง๐ž๐ฒ ๐€๐Œ ๐‘๐ž๐œ๐จ๐ ๐ง๐ข๐ฌ๐ž๐ ๐ข๐ง ๐€๐ฎ๐ฌ๐ญ๐ซ๐š๐ฅ๐ข๐š ๐ƒ๐š๐ฒ 2026 ๐‡๐จ๐ง๐จ๐ฎ๐ซ๐ฌ ๐‹๐ข๐ฌ๐ญ

Congratulations to Caitlin Delaney AM on being recognised in the Australia Day 2026 Honours List, announced by Her Excellency the Honourable Sam Mostyn AC, Governor-General of Australia.

Caitlin has been awarded a Member of the Order of Australia for significant service to cancer advocacy, care, research and awareness, and to embryology.

Diagnosed nine years ago with a rare and aggressive ovarian cancer, Caitlin has become a powerful advocate for people living with rare and less common cancers, driven by lived experience and a deep commitment to equity in cancer care.

She has been a valued part of the Chris O'Brien Lifehouse community, serving on our Partnership Advisory Council since 2022, representing patients within our Pharmacy Department, speaking at Chris Oโ€™Brien Lifehouse events, and helping train staff in Compassionate Patient Care.

Caitlinโ€™s advocacy for access to genomics, emerging science and supportive care continues to shape better outcomes for patients and their families.

Congratulations, Caitlin, on this well-deserved honour.

๐“๐š๐ซ๐ ๐ž๐ญ๐ž๐ ๐๐ซ๐š๐ข๐ง ๐‚๐š๐ง๐œ๐ž๐ซ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ข๐ž๐ฌ: ๐๐ซ๐จ๐ ๐ซ๐ž๐ฌ๐ฌ ๐š๐ง๐ ๐‘๐ž๐ฆ๐š๐ข๐ง๐ข๐ง๐  ๐๐š๐ซ๐ซ๐ข๐ž๐ซ๐ฌ Access to innovative medicines can be the difference be...
23/01/2026

๐“๐š๐ซ๐ ๐ž๐ญ๐ž๐ ๐๐ซ๐š๐ข๐ง ๐‚๐š๐ง๐œ๐ž๐ซ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ข๐ž๐ฌ: ๐๐ซ๐จ๐ ๐ซ๐ž๐ฌ๐ฌ ๐š๐ง๐ ๐‘๐ž๐ฆ๐š๐ข๐ง๐ข๐ง๐  ๐๐š๐ซ๐ซ๐ข๐ž๐ซ๐ฌ

Access to innovative medicines can be the difference between hope and hardship for people with cancer.

An ABC News article highlights the impact of vorasidenib, a targeted therapy offering new promise for people with IDH-mutant astrocytoma, and the challenges patients face when access is limited.

Sienna was in Year 12 when she found out she had a 3.6-centimetre astrocytoma tumour on her brain, including on one of her optic nerves. Following surgery, Associate Professor Hao-Wen Sim, Chris O'Brien Lifehouse Medical Oncologist, recommended vorasidenib as a treatment option for Sienna to help control residual tumour growth.

Vorasidenib is the first treatment in more than 30 years to target a broad group of IDH-mutant brain cancers, with the crucial ability to cross the bloodโ€“brain barrier, something earlier therapies were unable to do effectively.

As A/Prof Sim has explained, this unique mechanism is โ€œwhy we have high hopes for this particular drug" and its potential to change outcomes for patients who previously had few alternatives beyond monitoring, chemotherapy or radiotherapy.

Despite the high unmet clinical need, vorasidenib is not yet listed on the PBS, leaving families to absorb significant personal costs and limiting equitable access to care.

Reducing the burden of cancer means ensuring innovative, evidence-based treatments are accessible to all patients.

๐Ÿ”— https://www.abc.net.au/news/2026-01-20/brain-cancer-survivor-hoping-medication-can-get-pbs-listing/106163562

20/01/2026

๐“๐ก๐ž ๐‘๐จ๐ฅ๐ž ๐จ๐Ÿ ๐Ž๐ซ๐š๐ฅ ๐Œ๐ž๐๐ข๐œ๐ข๐ง๐ž ๐ข๐ง ๐Œ๐ฎ๐ฅ๐ญ๐ข๐๐ข๐ฌ๐œ๐ข๐ฉ๐ฅ๐ข๐ง๐š๐ซ๐ฒ ๐‚๐š๐ง๐œ๐ž๐ซ ๐‚๐š๐ซ๐ž

Associate Professor Sue-Ching Yeoh, COBL Oral Medicine Specialist, was recently featured on Mark Bourisโ€™ Project 100 podcast, where she shared expert insights into the role of oral medicine in detecting disease and supporting patient care.

In the episode, A/Prof Yeoh discusses the mouth as a key indicator of systemic disease, including head and neck cancers and HPV-related conditions, and explains how early oral signs can prompt timely referral and diagnosis.

The conversation highlights the importance of multidisciplinary collaboration across oral medicine, reinforcing how integrated care models support better outcomes for people with head and neck cancer.

Listen to the full episode here, https://www.youtube.com/watch?v=WexOXfoYrRc

15/01/2026

๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐“๐ซ๐ข๐š๐ฅ๐ฌ ๐ƒ๐ซ๐ข๐ฏ๐ข๐ง๐  ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐’๐ค๐ข๐ง ๐‚๐š๐ง๐œ๐ž๐ซ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ

A new clinical trial is underway to improve outcomes for people with squamous cell carcinoma (SCC), Australiaโ€™s second most common skin cancer. The study is exploring whether immunotherapy, a treatment that helps the bodyโ€™s own immune system recognise and attack cancer cells, can play a greater role in treating this disease.

With involvement from Chris Oโ€™Brien Lifehouse clinicians, including Professor Sydney Ch'ng, the trial is investigating whether giving immunotherapy before surgery can reduce the risk of the cancer returning and limit the need for extensive, life-altering procedures.

The study will enrol more than 420 patients across Australia, the United States and Canada, marking a significant international effort to advance SCC treatment.

This 9 News segment features patient COBL Arnold, who took part in an earlier immunotherapy trial and was able to avoid radical surgery. His experience offers insights into the potential impact this approach may have for future patients.

Advances in research and innovation play a key role in improving outcomes and enabling more personalised, patient-centred care.

๐‚๐ก๐ซ๐ข๐ฌ ๐Žโ€™๐๐ซ๐ข๐ž๐ง ๐‹๐ข๐Ÿ๐ž๐ก๐จ๐ฎ๐ฌ๐ž ๐‘๐ž๐œ๐จ๐ ๐ง๐ข๐ฌ๐ž๐ ๐š๐ฌ ๐š๐ง ๐ˆ๐€๐’๐ˆ๐Ž๐’ ๐€๐œ๐œ๐ซ๐ž๐๐ข๐ญ๐ž๐ ๐‚๐ž๐ง๐ญ๐ซ๐žThe International Accreditation for Interventional Onco...
13/01/2026

๐‚๐ก๐ซ๐ข๐ฌ ๐Žโ€™๐๐ซ๐ข๐ž๐ง ๐‹๐ข๐Ÿ๐ž๐ก๐จ๐ฎ๐ฌ๐ž ๐‘๐ž๐œ๐จ๐ ๐ง๐ข๐ฌ๐ž๐ ๐š๐ฌ ๐š๐ง ๐ˆ๐€๐’๐ˆ๐Ž๐’ ๐€๐œ๐œ๐ซ๐ž๐๐ข๐ญ๐ž๐ ๐‚๐ž๐ง๐ญ๐ซ๐ž

The International Accreditation for Interventional Oncology Services (IASIOS) has formally recognised Chris Oโ€™Brien Lifehouse (COBL) as an Accredited Centre for Interventional Oncology.

This accreditation acknowledges the strength of COBLโ€™s Interventional Oncology department, led by Dr Chris Rogan, Director of Interventional Oncology, and confirms the successful implementation of a standardised patient pathway aligned with international best practice. It reflects a strong focus on patient safety, quality, and consistency of care.

The Interventional Oncology team at COBL delivers minimally invasive cancer treatments using advanced imaging technologies, including X-ray, CT, MRI, and ultrasound, supporting both diagnostic and therapeutic procedures across a range of conditions.

Achieving IASIOS accreditation highlights an ongoing commitment to multidisciplinary collaboration, innovation, and continuous improvement in patient care.

๐‚๐ž๐ฅ๐ž๐›๐ซ๐š๐ญ๐ข๐ง๐  ๐„๐ฑ๐œ๐ž๐ฅ๐ฅ๐ž๐ง๐œ๐ž ๐ข๐ง ๐๐ž๐๐ฌ๐ข๐๐ž ๐“๐ž๐š๐œ๐ก๐ข๐ง๐ Congratulations to Dr Laura Sunderland, Gynaecological Oncology Registrar, on ...
08/01/2026

๐‚๐ž๐ฅ๐ž๐›๐ซ๐š๐ญ๐ข๐ง๐  ๐„๐ฑ๐œ๐ž๐ฅ๐ฅ๐ž๐ง๐œ๐ž ๐ข๐ง ๐๐ž๐๐ฌ๐ข๐๐ž ๐“๐ž๐š๐œ๐ก๐ข๐ง๐ 
Congratulations to Dr Laura Sunderland, Gynaecological Oncology Registrar, on receiving the 2025 David Church Memorial Award for Bedside Teaching, an honour nominated by medical students at the University of Sydneyโ€™s Central Clinical School.

โ€œItโ€™s honestly very humbling. Sharing knowledge is such an important part of the medical community, so to be recognised for that means a lot.โ€

For Dr Sunderland, bedside teaching goes beyond clinical facts. Itโ€™s about learning how to listen to patients, communicate with care, and explain complex information in ways that make sense.

Those moments when everything โ€œclicksโ€ for students are what make teaching so rewarding, and this award is a reflection of the impact she continues to have in the clinical setting.

06/01/2026

๐’๐ฎ๐ซ๐…๐ž๐›๐ซ๐ฎ๐š๐ซ๐ฒ: ๐‘๐ž๐ ๐ข๐ฌ๐ญ๐ซ๐š๐ญ๐ข๐จ๐ง๐ฌ ๐š๐ซ๐ž ๐ง๐จ๐ฐ ๐จ๐ฉ๐ž๐ง!

SurFebruary brings people together for a simple daily challenge: get in the water every day in February. Whether itโ€™s surfing, swimming or splashing, every dip helps support cancer research.

Entering its 9th year, SurFebruary continues to grow as a community-led movement and has helped create the SurFebruary Cancer Research Seed Fund, supporting research that benefits Australians nationwide.

Thinking about taking part in 2026? Registration is free and easy.

Join SurFebruary and be part of something thatโ€™s creating real impact for people affected by cancer, now and into the future.

Register today! https://www.surfebruary.com/

๐‡๐š๐ฉ๐ฉ๐ฒ ๐๐ž๐ฐ ๐˜๐ž๐š๐ซ!As we farewell 2025, we take pride in reflecting on a year defined by purpose, innovation, and dedication...
31/12/2025

๐‡๐š๐ฉ๐ฉ๐ฒ ๐๐ž๐ฐ ๐˜๐ž๐š๐ซ!

As we farewell 2025, we take pride in reflecting on a year defined by purpose, innovation, and dedication to our patients. This year saw remarkable progress across our research programs, with new studies launched, clinical trials advancing, and discoveries that continue to shape the future of cancer care.

Our staff represented COBL on national and international stages, sharing expertise, learning from global leaders, and earning recognition for their outstanding contributions to cancer care and research. Most importantly, we remained committed to delivering compassionate, patient-centred cancer care every single day.

Looking ahead to 2026, we are energised by the opportunities before us. We look forward to showcasing new research milestones, deepening our collaborations, and celebrating the extraordinary people who drive our mission forward. The coming year brings exciting opportunities for progress, and we remain committed to our vision to transform the lives of people affected by cancer.

Wishing our entire COBL community a joyful, safe, and happy new year! ๐ŸŽ‰

#2026

30/12/2025

It's been a big year for music at Chris O'Brien Lifehouse! ๐ŸŽถ

As the year comes to a close, weโ€™re reflecting on the incredible moments music has brought to patients at Chris Oโ€™Brien Lifehouse, moments of hope, comfort and connection.

Thereโ€™s still time to help Music in Health reach more patients in 2026. Your donation will support bedside therapy, group singing, live music in the atrium and so much more - all entirely funded by donors.

๐Ÿ’› Give the gift of music before the year ends. Donate today.
๐Ÿ”— https://donate.mylifehouse.org.au/XMAS

Address

119-143 Missenden Road
Camperdown, NSW
2050

Alerts

Be the first to know and let us send you an email when Chris O'Brien Lifehouse posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Chris O'Brien Lifehouse:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Your cancer centre

Chris Oโ€™Brien Lifehouse is a not-for-profit, comprehensive cancer hospital. From screening to prevention, diagnosis, treatment and wellness, we specialise in advanced care for patients with cancer, including the most rare and complex cases. Each year we treat over 57,000 patients from across Australia, using the latest technology in a modern, purpose-built hospital.

Chris Oโ€™Brien

Chris Oโ€™Brien was a man of leadership, vision and courage. He inspired people, both through his work as a cancer specialist and through his own three-year battle with an aggressive brain tumour. Chris transformed his personal adversity into a national opportunity, using his experience to fight so much harder for cancer patients and their families. Chrisโ€™ vision was for an integrated cancer treatment centre, where patients will no longer have to navigate their way through all the different elements of dealing with their illness alone. His vision was realised with the opening of Chris Oโ€™Brien Lifehouse to patients on 19 November 2013.

Leading cancer care